[키워드] accounted acute infection acute respiratory syndrome adjusted AEs Analysis approved calculate Clinical studies Concentration conducted coronavirus coronavirus disease Course COVID-19 COVID-19 patient database demonstrated dosages dose doses drug drugs EC50 Effects Efficacy Endpoint Evidence for inclusion in vitro India ingredient inhibit initiated margin Metrics nitazoxanide pandemic participant per day pharmacies Placebo Placebo-controlled trials plasma concentration Potential treatment promote raised randomised controlled trial RCT RCTs Replication reported required Research Result review Safe safety profile SARS-CoV-2 searched Serious Adverse Event shown significant difference teratogenic teratogenicity treat Treatment treatments for COVID-19 Trial trials
[DOI] 10.1016/S2055-6640(20)30017-0 [Article Type] Review article